HUP0100056A2 - Karbonsavval helyettesített, fém-proteináz-gátló hatású heterociklusos vegyületek, alkalmazásuk gyógyászati készítmények előállítására és a vegyületeket tartalmazó gyógyászati készítmények - Google Patents
Karbonsavval helyettesített, fém-proteináz-gátló hatású heterociklusos vegyületek, alkalmazásuk gyógyászati készítmények előállítására és a vegyületeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0100056A2 HUP0100056A2 HU0100056A HUP0100056A HUP0100056A2 HU P0100056 A2 HUP0100056 A2 HU P0100056A2 HU 0100056 A HU0100056 A HU 0100056A HU P0100056 A HUP0100056 A HU P0100056A HU P0100056 A2 HUP0100056 A2 HU P0100056A2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- acid substituted
- carboxyl acid
- metalloproteinase inhibitors
- substituted heterocycles
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 239000002253 acid Substances 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 239000003475 metalloproteinase inhibitor Substances 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000003449 preventive effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 230000004761 fibrosis Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 230000008354 tissue degradation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
A jelen találmány tárgya (I) általános képlétű fém-proteináz gátlóvegyületek vagy gyógyászatilag elfogadható sóik alkalmazása gyulladás,szöveti lebomlás, rák, fibrózis és hasonló betegségek gyógyító ésmegelőző kezelésére szolgáló gyógyászati készítmények előállítására. Atalálmány tárgya továbbá új vegyületek, analógjaik, prodrugjaik ésazok gyógyászatilag elfogadható sói, gyulladás, szöveti lebomlás éshasonló betegségek gyógyító és megelőző kezelésére szolgálógyógyászati készítmények. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6820097P | 1997-12-19 | 1997-12-19 | |
US09/213,031 US6335329B1 (en) | 1997-12-19 | 1998-12-16 | Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
PCT/US1998/027082 WO1999032452A1 (en) | 1997-12-19 | 1998-12-18 | Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0100056A2 true HUP0100056A2 (hu) | 2001-07-30 |
HUP0100056A3 HUP0100056A3 (en) | 2002-12-28 |
Family
ID=26748692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0100056A HUP0100056A3 (en) | 1997-12-19 | 1998-12-18 | Carboxyl acid substituted heterocycles as metalloproteinase inhibitors, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them |
Country Status (15)
Country | Link |
---|---|
US (5) | US6335329B1 (hu) |
EP (1) | EP1042297B1 (hu) |
JP (1) | JP2001526267A (hu) |
KR (1) | KR100446706B1 (hu) |
CN (1) | CN1110482C (hu) |
AT (1) | ATE233244T1 (hu) |
AU (1) | AU746957B2 (hu) |
CA (1) | CA2315826C (hu) |
DE (1) | DE69811734T2 (hu) |
DK (1) | DK1042297T3 (hu) |
ES (1) | ES2191986T3 (hu) |
HK (1) | HK1034964A1 (hu) |
HU (1) | HUP0100056A3 (hu) |
IL (2) | IL136717A0 (hu) |
WO (1) | WO1999032452A1 (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7037767B2 (en) * | 2003-03-24 | 2006-05-02 | Konica Minolta Holdings, Inc. | Thin-film transistor, thin-film transistor sheet and their manufacturing method |
US8177072B2 (en) * | 2008-12-04 | 2012-05-15 | Thermogenesis Corp. | Apparatus and method for separating and isolating components of a biological fluid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT72878B (en) | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5672598A (en) | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
DK0821671T3 (da) | 1995-04-20 | 2001-04-23 | Pfizer | Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer |
DK0861236T4 (da) | 1995-11-13 | 2006-12-18 | Sanofi Aventis Deutschland | Cykliske og heterocykliske N-substituerede alphaiminohydroxam- og carboxylsyrer |
FR2748026B1 (fr) | 1996-04-26 | 1998-06-05 | Adir | Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1998
- 1998-12-16 US US09/213,031 patent/US6335329B1/en not_active Expired - Fee Related
- 1998-12-18 KR KR10-2000-7006449A patent/KR100446706B1/ko not_active IP Right Cessation
- 1998-12-18 CN CN98813681A patent/CN1110482C/zh not_active Expired - Fee Related
- 1998-12-18 DK DK98964135T patent/DK1042297T3/da active
- 1998-12-18 AU AU19325/99A patent/AU746957B2/en not_active Ceased
- 1998-12-18 EP EP98964135A patent/EP1042297B1/en not_active Expired - Lifetime
- 1998-12-18 CA CA002315826A patent/CA2315826C/en not_active Expired - Fee Related
- 1998-12-18 DE DE69811734T patent/DE69811734T2/de not_active Expired - Fee Related
- 1998-12-18 AT AT98964135T patent/ATE233244T1/de not_active IP Right Cessation
- 1998-12-18 JP JP2000525389A patent/JP2001526267A/ja not_active Withdrawn
- 1998-12-18 IL IL13671798A patent/IL136717A0/xx not_active IP Right Cessation
- 1998-12-18 WO PCT/US1998/027082 patent/WO1999032452A1/en active IP Right Grant
- 1998-12-18 HU HU0100056A patent/HUP0100056A3/hu unknown
- 1998-12-18 ES ES98964135T patent/ES2191986T3/es not_active Expired - Lifetime
-
2000
- 2000-06-07 US US09/588,978 patent/US6291450B1/en not_active Expired - Fee Related
- 2000-06-12 IL IL136717A patent/IL136717A/en unknown
-
2001
- 2001-06-22 US US09/887,479 patent/US6593351B2/en not_active Expired - Fee Related
- 2001-08-08 HK HK01105515A patent/HK1034964A1/xx not_active IP Right Cessation
-
2003
- 2003-06-23 US US10/601,975 patent/US6838454B2/en not_active Expired - Fee Related
-
2004
- 2004-12-23 US US11/020,751 patent/US7022690B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2315826A1 (en) | 1999-07-01 |
HK1034964A1 (en) | 2001-11-09 |
DE69811734D1 (de) | 2003-04-03 |
ES2191986T3 (es) | 2003-09-16 |
US20040029863A1 (en) | 2004-02-12 |
IL136717A (en) | 2007-05-15 |
US20020065269A1 (en) | 2002-05-30 |
DK1042297T3 (da) | 2003-05-26 |
US6838454B2 (en) | 2005-01-04 |
KR100446706B1 (ko) | 2004-09-01 |
EP1042297A1 (en) | 2000-10-11 |
US6291450B1 (en) | 2001-09-18 |
US7022690B2 (en) | 2006-04-04 |
EP1042297B1 (en) | 2003-02-26 |
HUP0100056A3 (en) | 2002-12-28 |
KR20010033087A (ko) | 2001-04-25 |
AU1932599A (en) | 1999-07-12 |
US20050159407A1 (en) | 2005-07-21 |
JP2001526267A (ja) | 2001-12-18 |
US6335329B1 (en) | 2002-01-01 |
AU746957B2 (en) | 2002-05-09 |
US6593351B2 (en) | 2003-07-15 |
DE69811734T2 (de) | 2004-03-18 |
CN1284947A (zh) | 2001-02-21 |
CA2315826C (en) | 2004-09-14 |
CN1110482C (zh) | 2003-06-04 |
ATE233244T1 (de) | 2003-03-15 |
IL136717A0 (en) | 2001-06-14 |
WO1999032452A1 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2303629B (en) | Hydroxamic acids and their use as metalloproteinase inhibitors | |
HUP0402577A2 (hu) | Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra | |
HUP0402422A2 (hu) | Deuterizált szubsztituált pirazolil-benzolszulfonamid-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
MY128014A (en) | Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors | |
CA2274686A1 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
EP1086099A4 (en) | COMPOUNDS BASED ON SULFONIC ACID OR SULFONYLAMINO N- (HETEROARALKYL) -AZAHETEROCYCLYLAMIDE | |
HUP0202745A2 (hu) | Profilaktikus és terápiás szerek szembetegségek kezelésére | |
HUP0201284A2 (hu) | Hatóanyagként kinazolindionszármazék kimáz inhibitort tartalmazó gyógyászati készítmények fibrózis megelőzésére vagy kezelésére | |
HUP9902079A2 (hu) | A mátrix metalloproteinázok működését gátló aromás ketosavak és azok származékai | |
CA2314154A1 (en) | Azepine or larger medium ring derivatives and their use as pharmaceuticals | |
EP1019047A4 (en) | ANTITHROMBOTIC AGENTS | |
HUP0100056A2 (hu) | Karbonsavval helyettesített, fém-proteináz-gátló hatású heterociklusos vegyületek, alkalmazásuk gyógyászati készítmények előállítására és a vegyületeket tartalmazó gyógyászati készítmények | |
MA27157A1 (fr) | Methode de traitement d'affections osseuses. | |
DE60233578D1 (de) | Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung | |
NO974101L (no) | Anvendelse av penciclovir for behandling av human herpes virus-8 | |
HUP0100122A2 (hu) | Tiludronsav és származékai alkalmazása szárnyasok csontritkulásának megelőzésére és kezelésére szolgáló gyógyászati készítmény előállítására | |
HUP0200129A2 (hu) | N-(3'4'-dimetoxi-cinnamoil)-antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |